590 related articles for article (PubMed ID: 23395701)
1. Disparities in stage at diagnosis among adults with testicular germ cell tumors in the National Cancer Data Base.
Lerro CC; Robbins AS; Fedewa SA; Ward EM
Urol Oncol; 2014 Jan; 32(1):23.e15-21. PubMed ID: 23395701
[TBL] [Abstract][Full Text] [Related]
2. The association of insurance and stage at diagnosis among patients aged 55 to 74 years in the national cancer database.
Ward EM; Fedewa SA; Cokkinides V; Virgo K
Cancer J; 2010; 16(6):614-21. PubMed ID: 21131794
[TBL] [Abstract][Full Text] [Related]
3. Insurance status and disparities in disease presentation, treatment, and outcomes for men with germ cell tumors.
Markt SC; Lago-Hernandez CA; Miller RE; Mahal BA; Bernard B; Albiges L; Frazier LA; Beard CJ; Wright AA; Sweeney CJ
Cancer; 2016 Oct; 122(20):3127-3135. PubMed ID: 27500561
[TBL] [Abstract][Full Text] [Related]
4. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis.
Halpern MT; Ward EM; Pavluck AL; Schrag NM; Bian J; Chen AY
Lancet Oncol; 2008 Mar; 9(3):222-31. PubMed ID: 18282806
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
Kawai T; Tanaka Y;
Int J Urol; 2017 Feb; 24(2):124-128. PubMed ID: 27915468
[TBL] [Abstract][Full Text] [Related]
6. Testicular cancer among US men aged 50 years and older.
Ghazarian AA; Rusner C; Trabert B; Braunlin M; McGlynn KA; Stang A
Cancer Epidemiol; 2018 Aug; 55():68-72. PubMed ID: 29807233
[TBL] [Abstract][Full Text] [Related]
7. Recent trends in the incidence of testicular germ cell tumors in the United States.
Ghazarian AA; Trabert B; Devesa SS; McGlynn KA
Andrology; 2015 Jan; 3(1):13-8. PubMed ID: 25331158
[TBL] [Abstract][Full Text] [Related]
8. The National Cancer Data Base report on patterns of care for testicular carcinoma, 1985-1996.
Steele GS; Richie JP; Stewart AK; Menck HR
Cancer; 1999 Nov; 86(10):2171-83. PubMed ID: 10570449
[TBL] [Abstract][Full Text] [Related]
9. Future of testicular germ cell tumor incidence in the United States: Forecast through 2026.
Ghazarian AA; Kelly SP; Altekruse SF; Rosenberg PS; McGlynn KA
Cancer; 2017 Jun; 123(12):2320-2328. PubMed ID: 28241106
[TBL] [Abstract][Full Text] [Related]
10. Changes in epidemiologic features of testicular germ cell cancer: age at diagnosis and relative frequency of seminoma are constantly and significantly increasing.
Ruf CG; Isbarn H; Wagner W; Fisch M; Matthies C; Dieckmann KP
Urol Oncol; 2014 Jan; 32(1):33.e1-6. PubMed ID: 23395239
[TBL] [Abstract][Full Text] [Related]
11. Insurance status and survival disparities among nonelderly rectal cancer patients in the National Cancer Data Base.
Robbins AS; Chen AY; Stewart AK; Staley CA; Virgo KS; Ward EM
Cancer; 2010 Sep; 116(17):4178-86. PubMed ID: 20549764
[TBL] [Abstract][Full Text] [Related]
12. Insurance status is related to diffuse large B-cell lymphoma survival.
Han X; Jemal A; Flowers CR; Sineshaw H; Nastoupil LJ; Ward E
Cancer; 2014 Apr; 120(8):1220-7. PubMed ID: 24474436
[TBL] [Abstract][Full Text] [Related]
13. Insurance status and distant-stage disease at diagnosis among adolescent and young adult patients with cancer aged 15 to 39 years: National Cancer Data Base, 2004 through 2010.
Robbins AS; Lerro CC; Barr RD
Cancer; 2014 Apr; 120(8):1212-9. PubMed ID: 24474656
[TBL] [Abstract][Full Text] [Related]
14. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
Chen AY; Halpern MT; Schrag NM; Stewart A; Leitch M; Ward E
J Natl Cancer Inst; 2008 Apr; 100(7):462-74. PubMed ID: 18364506
[TBL] [Abstract][Full Text] [Related]
15. Second malignancies among survivors of germ-cell testicular cancer: a pooled analysis between 13 cancer registries.
Richiardi L; Scélo G; Boffetta P; Hemminki K; Pukkala E; Olsen JH; Weiderpass E; Tracey E; Brewster DH; McBride ML; Kliewer EV; Tonita JM; Pompe-Kirn V; Kee-Seng C; Jonasson JG; Martos C; Brennan P
Int J Cancer; 2007 Feb; 120(3):623-31. PubMed ID: 17096341
[TBL] [Abstract][Full Text] [Related]
16. Testicular germ cell tumours in Iceland: a nationwide clinicopathological study.
Agnarsson BA; Gudbjartsson T; Einarsson GV; Magnusson K; Thoroddsen A; Bergthorsson JT; Amundadottir L; Barkardottir RB; Björnsson J
APMIS; 2006 Nov; 114(11):779-83. PubMed ID: 17078858
[TBL] [Abstract][Full Text] [Related]
17. Recent developments in testicular germ cell tumor research.
van de Geijn GJ; Hersmus R; Looijenga LH
Birth Defects Res C Embryo Today; 2009 Mar; 87(1):96-113. PubMed ID: 19306344
[TBL] [Abstract][Full Text] [Related]
18. Adverse prognostic factors for testicular cancer-specific survival: a population-based study of 27,948 patients.
Fosså SD; Cvancarova M; Chen L; Allan AL; Oldenburg J; Peterson DR; Travis LB
J Clin Oncol; 2011 Mar; 29(8):963-70. PubMed ID: 21300926
[TBL] [Abstract][Full Text] [Related]
19. Association of insurance and race/ethnicity with disease severity among men diagnosed with prostate cancer, National Cancer Database 2004-2006.
Fedewa SA; Etzioni R; Flanders WD; Jemal A; Ward EM
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2437-44. PubMed ID: 20705937
[TBL] [Abstract][Full Text] [Related]
20. Widening socioeconomic disparities in cervical cancer mortality among women in 26 states, 1993-2007.
Simard EP; Fedewa S; Ma J; Siegel R; Jemal A
Cancer; 2012 Oct; 118(20):5110-6. PubMed ID: 22707306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
